Loading…

Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis

Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers of medicine 2014-06, Vol.8 (2), p.241-249
Main Authors: Pan, Jiangang, Liu, Mo, Zhou, Xing
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3
cites cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3
container_end_page 249
container_issue 2
container_start_page 241
container_title Frontiers of medicine
container_volume 8
creator Pan, Jiangang
Liu, Mo
Zhou, Xing
description Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.
doi_str_mv 10.1007/s11684-014-0328-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1530956995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>50099844</cqvip_id><sourcerecordid>1530956995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</originalsourceid><addsrcrecordid>eNp9UcGO0zAQjRCIXZX9AC7IiAuXgO0kTnxcVbAgrcQFztHEGbdeOU7Xjov2UzjxI_wTv8BULRXisJbsGY3fezP2K4qXgr8TnLfvkxCqq0suaFeyK_mT4lJy3ZRcyubpORftRXGV0h2nVSvRav28uJB1J7iq68vixxoCc2GJsMfkDHg2gHHe58TW4CdcFixvMkYXWMQxG6RgcowYKKXiDhaHYUnsu1u2LMyhnHIy_nC3h-T2yAYP44iRGSBK_P3rJ7sOLO9GWJBBGJnJU_akQlBqByUE8A_JpRfFMws-4dUpropvHz98XX8qb7_cfF5f35amrtulHMQIWA18UCCtNVy0FvSgpFASed3BWEmJklcWu7bTVlmrqFC3baOqUVmoVsXbo-4uzvcZ09JPLhn0HgLOOfWiqegnldYNQd_8B72bc6R5CaVr0XQtF5pQ4ogycU4pou130U0QH3rB-4N1_dG6nqzrD9bRsSpenZTzMOF4Zvw1igDyCEh0FTYY_2n9iGp3JG3dZovk3y5iSr2NcyDX4uPU16dHbOewuaeW55kazrXuaKY_ZQ7Euw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941587019</pqid></control><display><type>article</type><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><source>Springer Nature</source><creator>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</creator><creatorcontrib>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</creatorcontrib><description>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</description><identifier>ISSN: 2095-0217</identifier><identifier>EISSN: 2095-0225</identifier><identifier>DOI: 10.1007/s11684-014-0328-0</identifier><identifier>PMID: 24810644</identifier><language>eng</language><publisher>Heidelberg: Higher Education Press</publisher><subject>Administration, Intravesical ; bacillus Calmette-Guérin (BCG) ; BCG Vaccine - administration &amp; dosage ; BCG Vaccine - therapeutic use ; Bladder cancer ; Health risk assessment ; Humans ; Medicine ; Medicine &amp; Public Health ; Meta-analysis ; non-muscle invasive bladder cancer ; Randomized Controlled Trials as Topic ; Recurrence ; Research Article ; Urinary Bladder Neoplasms - drug therapy ; Urinary Bladder Neoplasms - prevention &amp; control ; 卡介苗 ; 复发 ; 患者 ; 浸润性 ; 累积 ; 肌 ; 膀胱癌 ; 辅助治疗</subject><ispartof>Frontiers of medicine, 2014-06, Vol.8 (2), p.241-249</ispartof><rights>Copyright reserved, 2014, Higher Education Press and Springer-Verlag Berlin Heidelberg</rights><rights>Higher Education Press and Springer-Verlag Berlin Heidelberg 2014</rights><rights>Frontiers of Medicine is a copyright of Springer, 2014.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</citedby><cites>FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/71235X/71235X.jpg</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24810644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Jiangang</creatorcontrib><creatorcontrib>Liu, Mo</creatorcontrib><creatorcontrib>Zhou, Xing</creatorcontrib><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><title>Frontiers of medicine</title><addtitle>Front. Med</addtitle><addtitle>Frontiers of Medicine</addtitle><description>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</description><subject>Administration, Intravesical</subject><subject>bacillus Calmette-Guérin (BCG)</subject><subject>BCG Vaccine - administration &amp; dosage</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Bladder cancer</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meta-analysis</subject><subject>non-muscle invasive bladder cancer</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Recurrence</subject><subject>Research Article</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><subject>Urinary Bladder Neoplasms - prevention &amp; control</subject><subject>卡介苗</subject><subject>复发</subject><subject>患者</subject><subject>浸润性</subject><subject>累积</subject><subject>肌</subject><subject>膀胱癌</subject><subject>辅助治疗</subject><issn>2095-0217</issn><issn>2095-0225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UcGO0zAQjRCIXZX9AC7IiAuXgO0kTnxcVbAgrcQFztHEGbdeOU7Xjov2UzjxI_wTv8BULRXisJbsGY3fezP2K4qXgr8TnLfvkxCqq0suaFeyK_mT4lJy3ZRcyubpORftRXGV0h2nVSvRav28uJB1J7iq68vixxoCc2GJsMfkDHg2gHHe58TW4CdcFixvMkYXWMQxG6RgcowYKKXiDhaHYUnsu1u2LMyhnHIy_nC3h-T2yAYP44iRGSBK_P3rJ7sOLO9GWJBBGJnJU_akQlBqByUE8A_JpRfFMws-4dUpropvHz98XX8qb7_cfF5f35amrtulHMQIWA18UCCtNVy0FvSgpFASed3BWEmJklcWu7bTVlmrqFC3baOqUVmoVsXbo-4uzvcZ09JPLhn0HgLOOfWiqegnldYNQd_8B72bc6R5CaVr0XQtF5pQ4ogycU4pou130U0QH3rB-4N1_dG6nqzrD9bRsSpenZTzMOF4Zvw1igDyCEh0FTYY_2n9iGp3JG3dZovk3y5iSr2NcyDX4uPU16dHbOewuaeW55kazrXuaKY_ZQ7Euw</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Pan, Jiangang</creator><creator>Liu, Mo</creator><creator>Zhou, Xing</creator><general>Higher Education Press</general><general>Springer Nature B.V</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</title><author>Pan, Jiangang ; Liu, Mo ; Zhou, Xing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Intravesical</topic><topic>bacillus Calmette-Guérin (BCG)</topic><topic>BCG Vaccine - administration &amp; dosage</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Bladder cancer</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meta-analysis</topic><topic>non-muscle invasive bladder cancer</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Recurrence</topic><topic>Research Article</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><topic>Urinary Bladder Neoplasms - prevention &amp; control</topic><topic>卡介苗</topic><topic>复发</topic><topic>患者</topic><topic>浸润性</topic><topic>累积</topic><topic>肌</topic><topic>膀胱癌</topic><topic>辅助治疗</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Jiangang</creatorcontrib><creatorcontrib>Liu, Mo</creatorcontrib><creatorcontrib>Zhou, Xing</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Frontiers of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Jiangang</au><au>Liu, Mo</au><au>Zhou, Xing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis</atitle><jtitle>Frontiers of medicine</jtitle><stitle>Front. Med</stitle><addtitle>Frontiers of Medicine</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>8</volume><issue>2</issue><spage>241</spage><epage>249</epage><pages>241-249</pages><issn>2095-0217</issn><eissn>2095-0225</eissn><abstract>Approximately 70% of newly diagnosed bladder tumors are non-muscle invasive bladder cancer (NMIBC). NMIBC accounts for approximately 80% of total bladder cancer cases. Bacillus Calmette-Guérin (BCG) instillation and maintenance is considered as the standard adjuvant treatment for superficial bladder cancer. A number of randomized studies have focused on the benefit of maintenance therapy following initial BCG induction. To provide further insights into the effect of intravesical instillation on recurrence in patients with NMIBC, we analyzed this relationship by conducting an updated detailed meta-analysis. Evidence suggested that adjuvant intravesical BCG with maintenance treatment is significantly effective for the prophylaxis of tumor recurrence in patients with NMIBC.</abstract><cop>Heidelberg</cop><pub>Higher Education Press</pub><pmid>24810644</pmid><doi>10.1007/s11684-014-0328-0</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2095-0217
ispartof Frontiers of medicine, 2014-06, Vol.8 (2), p.241-249
issn 2095-0217
2095-0225
language eng
recordid cdi_proquest_miscellaneous_1530956995
source Springer Nature
subjects Administration, Intravesical
bacillus Calmette-Guérin (BCG)
BCG Vaccine - administration & dosage
BCG Vaccine - therapeutic use
Bladder cancer
Health risk assessment
Humans
Medicine
Medicine & Public Health
Meta-analysis
non-muscle invasive bladder cancer
Randomized Controlled Trials as Topic
Recurrence
Research Article
Urinary Bladder Neoplasms - drug therapy
Urinary Bladder Neoplasms - prevention & control
卡介苗
复发
患者
浸润性
累积

膀胱癌
辅助治疗
title Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A47%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20intravesical%20bacillus%20Calmette-Guerin%20reduce%20recurrence%20in%20patients%20with%20non-muscle%20invasive%20bladder%20cancer%EF%BC%9F%20An%20update%20and%20cumulative%20meta-analysis&rft.jtitle=Frontiers%20of%20medicine&rft.au=Pan,%20Jiangang&rft.date=2014-06-01&rft.volume=8&rft.issue=2&rft.spage=241&rft.epage=249&rft.pages=241-249&rft.issn=2095-0217&rft.eissn=2095-0225&rft_id=info:doi/10.1007/s11684-014-0328-0&rft_dat=%3Cproquest_cross%3E1530956995%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-b1dae3b0b6a2ffc017fa9b62162e048ad322e203fe8789f6ff622e477563d6fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1941587019&rft_id=info:pmid/24810644&rft_cqvip_id=50099844&rfr_iscdi=true